Treatment of Opioid Use Disorder: Use of Naltrexone Part 1

Evaluation and Claim Credit

1. Once you begin the video, you must watch it in its entirety to claim credit. Fast-forwarding has been disabled. You may pause the video briefly if needed. Do not close the browser window as doing so will require you to start over.
2. Once you have reached the end of the video, a button to continue will appear that will take to evaluation and start the process for receiving a certificate.
3. Failure to complete the process will result in the credit not being awarded to you.
4. Should you need to restart the process, or download a copy of a certificate at a later time, please see the instructions for accessing the online portal here: Evaluation and Claim Credit

For questions concerning the online evaluation or your certificate, please contact our office at (775) 784-4791 or email us at cme@med.unr.edu.

Accreditation Designation Statements

The University of Nevada, Reno School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Nevada, Reno School of Medicine designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Education Credit

The University of Nevada, Reno School of Medicine approves this program for 1.00 hour of nursing continuing education credit. Nevada State Board of Nursing provider number 120894-1.

This program provides 0.50 CME credit(s) toward the Nevada State Board of Medical Examiners' requirement for 2 hours of training related to the misuse and abuse of controlled substances, the prescribing of opioids, or addiction during each licensure period.

As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of an accredited activity disclose all financial relationships within the prior 24 months with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. All relevant financial relationships have been mitigated. Following are those disclosures.

All other presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that they do not have financial relationships with ineligible companies related to the content of this activity.

• Baron, D., Garbely, J., Boyd, R. (2009). Evaluation and management of substance abuse emergencies. Clinical Focus16(9):41-47.
• Brummett, C. M., Waljee, J. F., Goesling, J., Moser, S., Lin, P., Englesbe, M. J., . . .Nallamothu, B. K. (2017). New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surgery, 152(6), e170504. doi:10.1001/jamasurg.2017.0504
• Krupitsky, E., Prof, Nunes, E. V., Prof, Ling, W., Prof, Illeperuma, A., MA, Gastfriend, D. R., MD, & Silverman, B. L., MD. (2011). Injectable extended-release naltrexone or opioid dependence: A double-blind, placebo-controlled, multicenter randomised trial. Lancet, 377(9776), 1506-1513. doi:10.1016/S0140 6736(11)60358-9
• Volkow, N. D., Chang, L., Wang, G., Fowler, J. S., Franceschi, D., Sedler, M., . . .Logan, J. (2001). Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. Journal of Neuroscience, 21(23), 9414 9418